WHO ICTRP trial
Evaluation of the clinical efficacy of Yi Xin prescription in the treatment of…
ChiCTR2400085509 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2400085509 |
|---|---|
| Public title | Evaluation of the clinical efficacy of Yi Xin prescription in the treatment of heart failure with preserved ejection fraction in the type of qi deficiency and blood stasis |
| Scientific title | Evaluation of the clinical efficacy of Yi Xin prescription in the treatment of heart failure with preserved ejection fraction in the type of qi deficiency and blood stasis |
| Primary sponsor | Yueyang Hospital of Integrated Traditional Chinese Medicien and Western Medicine, Shanghai University of Traditional Chinese Medicine |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | Heart failure with preserved ejection fraction in the type of qi deficiency and blood stasis |
| Interventions | Treatment group:Standardized treatment + Yixin prescription;Control group:Standardized treatment + placebo pellets |
| Registration date | Jun 11, 2024 |
| Target size | Treatment group:50;Control group:50 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: